Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

Podcasts
A Payer's Perspective on Value-Based Care and Treatment Costs for Rheumatic Conditions
11/06/2023

Featuring Steven Peskin, MD, CEO, SRP Advisors

Featuring Steven Peskin, MD, CEO, SRP...
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general...
11/06/2023
First Report Managed Care
Headshot of Derek Streat on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Problems and Innovations in Streamlining Virtual Care Services
09/29/2023

Featuring Derek Streat, DexCare

Featuring Derek Streat, DexCare ...
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO,...
09/29/2023
Integrated Healthcare Executive
Headshot of Anthony Watson on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Payer Reimbursement and Prescription Digital Therapeutics: Understanding FDA Regulations
06/29/2023
Julie Gould
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice...
06/29/2023
First Report Managed Care

Advertisement

Headshot of Rimal Bera, UC Irvine, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Selecting Atypical Antipsychotics for Patients With Bipolar Disorder
06/20/2023

Featuring Rimal Bera, MD

Featuring Rimal Bera, MD
Rimal Bera, MD, clinical professor of psychiatry, University of California, Irvine, breaks down major factors in selecting antipsychotics for bipolar disorder and the importance of treatments with high adherence rates.
Rimal Bera, MD, clinical professor of psychiatry, University of California, Irvine, breaks down major factors in selecting antipsychotics for bipolar disorder and the importance of treatments with high adherence rates.
Rimal Bera, MD, clinical...
06/20/2023
Veterans Health Today
Headshot of Clement Chung, Houston Methodist, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Considerations for Selecting Small Molecule Inhibitors for Patients With CLL
05/26/2023
Maria Asimopoulos
Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...
Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...
Clement Chung, PharmD, MS, BCOP,...
05/26/2023
First Report Managed Care
Headshot of Russell Spjut on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Understanding Regulatory Pathways for Prescription Digital Therapeutics From a PBM, Payer Perspective
03/30/2023
Edan Stanley
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director,...
03/30/2023
First Report Managed Care

Advertisement

Russell Spjut
Podcasts
PDTs vs DTx: What’s the Difference?
03/21/2023
Edan Stanley
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director,...
03/21/2023
First Report Managed Care
Headshot of John Tesser, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Combining Pegloticase With Methotrexate Bolsters Response Rate in Patients With Chronic Gout
03/02/2023
Maria Asimopoulos
John RP Tesser, MD, rheumatology specialist, Arizona Arthritis & Rheumatology Associates, and clinical adjunct professor, Midwestern University College of Health Sciences, discusses the MIRROR trial, a study which showed the addition of an...
John RP Tesser, MD, rheumatology specialist, Arizona Arthritis & Rheumatology Associates, and clinical adjunct professor, Midwestern University College of Health Sciences, discusses the MIRROR trial, a study which showed the addition of an...
John RP Tesser, MD, rheumatology...
03/02/2023
First Report Managed Care

Advertisement

Craig Gravina, chief technology officer, ObvioHealth
Podcasts
Navigating the Path to Approval for PDTs Using Decentralized Clinical Trials
02/27/2023
Edan Stanley
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology...
02/27/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

What's Trending?

Diving Into Dementia
When Living at Home Is No Longer Possible
12/10/2018

Freddi Segal-Gidan, PA-C, PhD—Column Editor

Freddi Segal-Gidan, PA-C, PhD—Column ...
Clinical interventions that better prepare families, particularly the primary family caregiver, for possible placement and for the transition in care and the caregiving role would have potential benefit for all, including the patient, family,...
Clinical interventions that better prepare families, particularly the primary family caregiver, for possible placement and for the transition in care and the caregiving role would have potential benefit for all, including the patient, family,...
Clinical interventions that...
12/10/2018
Annals of Long-Term Care
News
U.S. Nursing Home Chain HCR ManorCare to Sell Itself in Bankruptcy
03/02/2018
The second-largest US nursing home operator, HCR ManorCare, will file for Chapter 11 protection in the coming days and transfer ownership to its landlord, Quality Care Properties Inc, the latest sign of distress in the senior housing...
The second-largest US nursing home operator, HCR ManorCare, will file for Chapter 11 protection in the coming days and transfer ownership to its landlord, Quality Care Properties Inc, the latest sign of distress in the senior housing...
The second-largest US nursing...
03/02/2018
Annals of Long-Term Care
News
FDA Has Approved 35 Drugs in 2014, Already Surpassed 2013 Numbers
12/17/2014
According to the FDA commissioner, Margaret Hamburg, the agency has approved 35 novel drugs so far in 2014 compared to 27 in 2013.
According to the FDA commissioner, Margaret Hamburg, the agency has approved 35 novel drugs so far in 2014 compared to 27 in 2013.
According to the FDA...
12/17/2014
First Report Managed Care
Headshot of Raymond Douglas on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Thyroid Eye Disease Treatment Shows Long-Term Effectiveness
07/28/2021
Maria Asimopoulos
Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program, Cedars-Sinai Medical Center, discusses the treatment efficacy of Tepezza (teprotumumab) in a variety of patients with thyroid eye disease, including how this...
Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program, Cedars-Sinai Medical Center, discusses the treatment efficacy of Tepezza (teprotumumab) in a variety of patients with thyroid eye disease, including how this...
Raymond Douglas, MD, PhD,...
07/28/2021
Population Health
News
Lewy body disease, Alzheimer`s tied to distinct types of gait impairment
09/24/2019
By Reuters StaffNEW...
By Reuters StaffNEW...
...
09/24/2019
Population Health

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use